Condition: Infant Growth · Sponsor: Biostime (Changsha) Nutrition Foods Limited
Randomized, controlled study consisting of three parallel arms to investigate the effects of novel infant formula on growth, gut health, immune function, and sleep status in healthy infants and young children aged 12-18 months.
This description comes directly from the study's public registry record.
Pantian Huang · +86 13430375474 · umi.huang@hh.global
Siwan Peng · +86 13543117452 · pengsiwan@zhunter.com.cn
Always discuss trial participation with your own doctor first.
| Shenzhen University | Shenzhen, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07534735